JP Morgan Chase
EHC icon

JP Morgan Chase’s Encompass Health EHC Stock Holding History

JP Morgan Chase’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-34,316
Closed -$1.94M – 6550
2022
Q1 		$1.94M Buy
+34,316
New +$1.79M ﹤0.01% 3775
2021
Q3 		– Sell
-168,941
Closed -$10.5M – 6547
2021
Q2 		$10.5M Buy
+168,941
New +$11.3M ﹤0.01% 2388
2021
Q1 		– Sell
-74,414
Closed -$4.89M – 6127
2020
Q4 		$4.89M Buy
+74,414
New +$4.38M ﹤0.01% 2830

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase's EHC Position: Q2 2026 in Review

JP Morgan Chase reduced its Encompass Health (EHC) stake by 8% in Q2 2026, selling an estimated $10.1M and leaving 1,133,561 shares worth $115M. The position accounts for 0.01% of the portfolio, ranked #995.

JP Morgan Chase first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $258M in Q1 2021. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • JP Morgan Chase held 1,133,561 shares of Encompass Health worth $115M as of Q2 2026.
  • JP Morgan Chase sold 97,910 Encompass Health shares in Q2 2026, an estimated $10.1M.
  • Encompass Health made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #995 holding.
  • JP Morgan Chase first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Encompass Health position peaked at $258M in Q1 2021.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.